Published on : Apr 22, 2016
ALBANY, New York, April 22, 2016: The research report provides a detailed analysis of the global market for in vitro diagnostics, including a detailed overview of the market, deal trends, prominent players, top deal values, and financials deals. The study further elaborates on under what terms the major companies are allowed to participate in the in vitro diagnostics (IVD) market and its partnering deals. The research report offers all the key factors that are required for a prospective dealmaker. It provides information regarding partnering in the research and development and commercialization of the IVD technologies and products.
The research study, titled “Global In Vitro Diagnostics 2010-2016: Deal trends, players, financials and forecasts,” further provides details of the recent IVD agreements that have been announced in the life sciences field in the last few years. The deals are anticipated to be multicomponent, along with collaborative research and development and commercialization of the outcomes. In addition, the study includes the financial deal term values for the IVD deals, including upfront payments, headline value, royalties, and milestone payments. It helps the readers and decision-makers in analyzing and benchmarking the financial value of the deals.
In vitro diagnostics refers to a medical technology and the related devices that are widely used to perform several tests on samples in order to monitor drug therapies, diagnose a medical condition, and prevent diseases. IVD devices can range from basic tests to further sophisticated DNA technology, including control materials, calibrators, kits, software, reagents, and related instruments. The global IVD market majorly finds application in patient self-testing, hospitals, point-of-care testing, laboratories, academic institutes, and others.
Click here to get more info with TOC in a PDF Format: https://www.researchmoz.us/enquiry.php?type=S&repid=686341
The growing geriatric population worldwide, increasing adoption of point-of-care testing, growing prevalence of chronic lifestyle diseases, and increasing awareness regarding personalized medicine are some of the major factors that are estimated to fuel the growth of the global IVD market throughout the forecast period. Moreover, the increasing healthcare expenditure in developing economies and introduction of condition-specific tests and markers with advances in proteomics and genomics are the key growth opportunities for the major players operating in the market.
On the flip side, the implementation of excise duty by the U.S. government and inadequate reimbursement are some of the key factors that are expected to hamper the growth of the overall IVD market in the next few years.
Furthermore, the research report covers the vendor analysis of the global market for in vitro diagnostics. A thorough analysis of the major players has been included in the scope of the study. The prominent players operating in the market are Becton, Dickinson and Company, Ortho-Clinical Diagnostics, Siemens Healthcare, Danaher Corporation, Johnson and Johnson, Roche Diagnostics, bioMérieux, Sysmex Corporation, Abbott Laboratories, Inc., Bio-Rad Laboratories, Inc., and Thermo Fisher Scientific, Inc.
To order report Call USA – Canada Toll Free: 866-997-4948 or send an email on [email protected]